1. Home
  2. ABT vs HSBC Comparison

ABT vs HSBC Comparison

Compare ABT & HSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABT
  • HSBC
  • Stock Information
  • Founded
  • ABT 1888
  • HSBC 1865
  • Country
  • ABT United States
  • HSBC United Kingdom
  • Employees
  • ABT N/A
  • HSBC N/A
  • Industry
  • ABT Medical/Dental Instruments
  • HSBC Savings Institutions
  • Sector
  • ABT Health Care
  • HSBC Finance
  • Exchange
  • ABT Nasdaq
  • HSBC Nasdaq
  • Market Cap
  • ABT 221.0B
  • HSBC N/A
  • IPO Year
  • ABT N/A
  • HSBC N/A
  • Fundamental
  • Price
  • ABT $131.91
  • HSBC $57.97
  • Analyst Decision
  • ABT Buy
  • HSBC Buy
  • Analyst Count
  • ABT 18
  • HSBC 1
  • Target Price
  • ABT $136.06
  • HSBC N/A
  • AVG Volume (30 Days)
  • ABT 7.0M
  • HSBC 2.4M
  • Earning Date
  • ABT 04-16-2025
  • HSBC 04-29-2025
  • Dividend Yield
  • ABT 1.79%
  • HSBC 7.47%
  • EPS Growth
  • ABT 134.36
  • HSBC 8.77
  • EPS
  • ABT 7.64
  • HSBC 1.24
  • Revenue
  • ABT $41,950,000,000.00
  • HSBC $61,253,000,000.00
  • Revenue This Year
  • ABT $6.72
  • HSBC $8.82
  • Revenue Next Year
  • ABT $7.39
  • HSBC $1.91
  • P/E Ratio
  • ABT $17.27
  • HSBC $46.75
  • Revenue Growth
  • ABT 4.59
  • HSBC 8.70
  • 52 Week Low
  • ABT $99.71
  • HSBC $39.42
  • 52 Week High
  • ABT $141.23
  • HSBC $61.88
  • Technical
  • Relative Strength Index (RSI)
  • ABT 54.57
  • HSBC 54.57
  • Support Level
  • ABT $130.64
  • HSBC $56.52
  • Resistance Level
  • ABT $133.46
  • HSBC $58.89
  • Average True Range (ATR)
  • ABT 2.59
  • HSBC 0.70
  • MACD
  • ABT 0.33
  • HSBC -0.20
  • Stochastic Oscillator
  • ABT 82.70
  • HSBC 59.11

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Share on Social Networks: